Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A2J35 | IM |
received a MMR vaccine intramuscularly; 45 years patient received Priorix vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 45-year-old female patient who received MMR (Priorix) (batch number A2J35, expiry date 01-SEP-2025) for prophylaxis. On 14-JAN-2025, the patient received Priorix (intramuscular, unknown deltoid). On 14-JAN-2025, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: received a MMR vaccine intramuscularly) and inappropriate age at vaccine administration (Verbatim: 45 years patient received Priorix vaccine). The outcome of the subcutaneous injection formulation administered by other route and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-JAN-2025 The nurse practitioner reported that they had a patient who received a MMR vaccine (Priorix) two days ago and she received that yesterday. The reporter asked it was a live vaccine and was that correct and she received a MMR vaccine intramuscularly and she got it in the deltoid, which led to subcutaneous injection formulation administered by other route The reporter was told that it was not a live vaccine and she received it on the deltoid and was needing her varicella today which she could not give her if she received the MMR two days ago. The reporter asked that something that they need to repeat whether subcutaneously. The reporter asked do she need to wait and what was it that they need to do at that point, since it was administered incorrectly The patient received Priorix at inappropriate age which led to inappropriate age at vaccine administration.